Organization
Surge Therapeutics
3 clinical trials
Clinical trial
A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder CancerStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase 1 Study of SRG-514 Administered Intraoperatively to the Site of Tumor Resection of Patients Undergoing Breast-Conserving Cancer SurgeryStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Phase 1 Dose Escalation Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical ProstatectomyStatus: Not yet recruiting, Estimated PCD: 2025-12-01